Evidence map›Paper›PMID 26380761›Full record

ReviewJournal of thoracic disease2015

Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea.

Brian D Kent, Walter T McNicholas, Silke Ryan

Open access · greenAbstract readReview
In one paragraph

Review in Journal of thoracic disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 1 pooled it
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 1 synthesis or guideline pooled it, 126 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Effect of obstructive sleep apnea on glucose metabolism.European journal of endocrinology · 2022
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Longitudinal Sleep Patterns and Risk of Type 2 Diabetes Mellitus.Diabetes/metabolism research and reviews · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Brian D Kent1 Pulmonary and Sleep Disorders Unit, Guy's and St Thomas' Hospital, London, UK ; 2 Pulmonary and Sleep Disorders Unit, St. Vincent's University Hospital, Dublin; Ireland ; 3 School of Medicine and Medical Science, University College Dublin, Dublin, Ireland.
Walter T McNicholas1 Pulmonary and Sleep Disorders Unit, Guy's and St Thomas' Hospital, London, UK ; 2 Pulmonary and Sleep Disorders Unit, St. Vincent's University Hospital, Dublin; Ireland ; 3 School of Medicine and Medical Science, University College Dublin, Dublin, Ireland.
Silke Ryan1 Pulmonary and Sleep Disorders Unit, Guy's and St Thomas' Hospital, London, UK ; 2 Pulmonary and Sleep Disorders Unit, St. Vincent's University Hospital, Dublin; Ireland ; 3 School of Medicine and Medical Science, University College Dublin, Dublin, Ireland.
St Thomas' Hospital · GBUniversity College Dublin · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obstructive sleep apnoea (OSA) is a highly prevalent disorder, which conveys an increased risk of cardiovascular disease and death. Type 2 diabetes mellitus (T2DM), glucose intolerance and insulin resistance (IR) are common in subjects with OSA, but a shared intimate relationship with obesity makes discerning an independent link challenging. Nonetheless, mechanistic studies suggest that OSA could contribute to impaired glucose metabolism via the effects of sleep fragmentation, sympathetic excitation and intermittent hypoxia (IH) on pancreatic B-cell function, insulin sensitivity, and systemic inflammation. In particular, emerging data suggest that IH may have an important detrimental effect on adipose tissue function and inflammation. Similarly, data from population-and clinic-level studies suggest that OSA is independently related with the prevalence and incidence of T2DM and IR, and may also lead to worse glycaemic control in diabetics. However, the ability of continuous positive airway pressure (CPAP) therapy to make a meaningful impact on T2DM or IR remains uncertain. In this review we explore the available evidence linking OSA with IR, glucose intolerance and T2DM, and discuss potential pathobiological mechanisms by which sleep disordered breathing can affect metabolic health.

Indexed as

diabetes mellitusinflammationinsulin resistance (IR)intermittent hypoxia (IH)Obstructive sleep apnoea (OSA)

Identifiers

PMID26380761
PMCPMC4561252
OpenAlexW2156628586

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.